Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Is there more than meets the eye to Healthia’s expansion into optometry?

  • In Opinion
  • January 25, 2021
  • Alfred Chan
Is there more than meets the eye to Healthia’s expansion into optometry?

With 13.2 million Australians suffering from long term eye problems, the rationale behind Healthia’s (ASX: HLA) $43m acquisition of The Optical Company was a logical opportunity to expand and investors have taken notice with HLA shares trading at all-time highs over the past month.

While it may appeared a simple tack-on acquisition, such price movement may have been driven by their track record when previously consolidating the fragmented podiatry and physiotherapy sectors.

Frames and Distribution Business
The inclusion of Australian Eyewear Distributors (AED), a frames distribution business, has been key to The Optical Company’s $5.6m underlying EBITDA where they have significantly greater ownership over their supply chain than independent operators.

The model follows a similar setup to Healthia’s Feet & Ankles division which is supplied 3D-printed orthotics by iOrthotics as a high-margin product that can be easily supplied to their podiatry customers, coupled with their retail footwear business.

AED has both wholesale and online offerings which cover both designer and inhouse brands, high-margin products where a single pair of frames will range from $99 upwards. Further securing recurring revenues for Healthia, frames are commonly purchased by those who wear glasses more regularly than their product lifespan courtesy of private health insurance customers who have annual rebates that lapse if not used each calendar year.

Given Healthia’s industry-leading expertise in 3D-printed healthcare products, 3D-printed frames may be closer to reality than the market realises.

Multi-Purpose Clinics and Audiology
One of the key drivers behind Healthia’s organic growth is the optimisation of clinic floor space whereby a physiotherapy clinic can be expanded to include podiatry and other company owned services.

At present, The Optical Company only offers optometry services but wheels are in motion to introduce audiology services which would come at minimal expense to Healthia using the same multipurpose clinic model. Although audiology services are less common than optometry, adoption is expected to grow alongside Australia’s aging population, notably where there is a higher population of elderly Australians in Queensland.

Increased screen time due to the rise of smart devices and laptop computers has resulted in greater need for optometry services. Meanwhile, the long-term effects of modern listening devices (headphones and earbuds) are not fully known, and could further the need for audiology care in the future, potentially at a younger age than current hearing device needs.

While audiology will be the initial service integrated into optometry clinics, Superclinics are a common trend in the United States where multiple allied health services are rolled into one location, providing ease-ofaccess to customers. The concept of Superclinics is something Healthia is already exploring with a new clinic in Bundaberg purpose-built to offer physiotherapy, occupational therapy, podiatry, exercise physiology, clinical Pilates, remedial massage and personal training all from one location.

Cross Referral & Loyalty Incentive
In our data-driven world, Healthia has harnessed the use of data analytics where marketing support services appear to be one of the key attractors to clinic owners that enquire about joining the Healthia network. Through the collection of demographic, health insurance and spending data, Healthia is able to promote better patient outcomes with predictive analytics that suggest when it might be a good time to visit the podiatrist or physiotherapist for a checkup.

Key to realising the full potential of this marketing support will be integration of The Optical Company into Healthia’s operating systems. The process endured headwinds when merging their physiotherapy and podiatry clinics into the single national system but once overcome, organic growth jumped from 2% in FY19 to 5.3% in FY20.

With that experience, Healthia has flagged integration of The Optical Group into their company-wide system over the coming six months which will provide opportunities to cross-refer patients between all three operating divisions where Healthia has also flagged plans to launch a loyalty program.

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • allied health services
  • allied healthcare
  • asx hla
  • healthcare
  • healthia
  • HLA
  • optometry
  • the optical company
  • Opinion

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.